Jennison Associates
OCDX

Jennison Associates’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Jennison Associates’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,216,729
Closed -$26M – 733
2021
Q4 		$26M Buy
1,216,729
+334,161
+38% +$6.58M 0.02% 321
2021
Q3 		$16.3M Buy
882,568
+151,120
+21% +$3.04M 0.01% 394
2021
Q2 		$15.7M Sell
731,448
-74,830
-9% -$1.52M 0.01% 407
2021
Q1 		$15.6M Buy
+806,278
New +$14.2M 0.01% 382

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Jennison Associates's OCDX Position: Q1 2022 in Review

Jennison Associates sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 1,216,729 shares — an estimated $26M sold.

Jennison Associates first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $26M in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Jennison Associates reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Jennison Associates sold 1,216,729 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $26M.
  • Jennison Associates first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
  • Jennison Associates's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $26M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Jennison Associates's 13F filing for Q1 2022, filed 11 May 2022.